Raymond James (NYSE:RJF – Free Report) – Equities researchers at Zacks Research boosted their Q1 2025 earnings per share estimates for Raymond James in a research report issued on Friday, November 15th. Zacks Research analyst R. Department now anticipates that the financial services provider will earn $2.67 per share for the quarter, up from their previous forecast of $2.59. The consensus estimate for Raymond James’ current full-year earnings is $10.83 per share. Zacks Research also issued estimates for Raymond James’ Q2 2025 earnings at $2.52 EPS, Q3 2025 earnings at $2.61 EPS, Q4 2025 earnings at $2.82 EPS, FY2025 earnings at $10.62 EPS, Q1 2026 earnings at $2.69 EPS and FY2026 earnings at $11.22 EPS.
Raymond James (NYSE:RJF – Get Free Report) last announced its earnings results on Wednesday, October 23rd. The financial services provider reported $2.95 EPS for the quarter, topping the consensus estimate of $2.41 by $0.54. The company had revenue of $3.46 billion for the quarter, compared to analysts’ expectations of $3.32 billion. Raymond James had a return on equity of 19.61% and a net margin of 13.86%. The business’s revenue for the quarter was up 13.4% on a year-over-year basis. During the same quarter in the prior year, the business earned $2.13 earnings per share.
Raymond James Price Performance
Shares of RJF opened at $160.68 on Monday. The company has a current ratio of 1.02, a quick ratio of 0.99 and a debt-to-equity ratio of 0.41. Raymond James has a 1 year low of $102.42 and a 1 year high of $163.45. The stock has a market cap of $33.09 billion, a P/E ratio of 16.55, a price-to-earnings-growth ratio of 0.81 and a beta of 0.99. The stock’s 50-day moving average price is $135.23 and its two-hundred day moving average price is $124.53.
Raymond James Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Tuesday, October 15th. Stockholders of record on Tuesday, October 1st were paid a $0.45 dividend. The ex-dividend date was Tuesday, October 1st. This represents a $1.80 annualized dividend and a dividend yield of 1.12%. Raymond James’s payout ratio is 18.54%.
Institutional Investors Weigh In On Raymond James
Hedge funds have recently added to or reduced their stakes in the company. Wellington Management Group LLP lifted its holdings in shares of Raymond James by 31.4% in the third quarter. Wellington Management Group LLP now owns 12,114,502 shares of the financial services provider’s stock valued at $1,483,542,000 after purchasing an additional 2,898,242 shares in the last quarter. Ceredex Value Advisors LLC lifted its holdings in shares of Raymond James by 191.3% in the third quarter. Ceredex Value Advisors LLC now owns 722,393 shares of the financial services provider’s stock valued at $88,464,000 after purchasing an additional 474,443 shares in the last quarter. AGF Management Ltd. lifted its holdings in shares of Raymond James by 17.2% in the second quarter. AGF Management Ltd. now owns 2,580,467 shares of the financial services provider’s stock valued at $318,972,000 after purchasing an additional 378,033 shares in the last quarter. Two Sigma Advisers LP bought a new position in shares of Raymond James in the third quarter valued at approximately $34,105,000. Finally, Worldquant Millennium Advisors LLC bought a new position in shares of Raymond James in the third quarter valued at approximately $28,985,000. Institutional investors and hedge funds own 83.83% of the company’s stock.
Raymond James Company Profile
Raymond James Financial, Inc, a financial holding company, through its subsidiaries, engages in the underwriting, distribution, trading, and brokerage of equity and debt securities, and the sale of mutual funds and other investment products in the United States, Canada, Europe, and internationally. The company operates through Private Client Group, Capital Markets, Asset Management, RJ Bank, and Other segments.
Featured Stories
- Five stocks we like better than Raymond James
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- Ride Out The Recession With These Dividend KingsĀ
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- Insider Trading – What You Need to Know
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for Raymond James Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Raymond James and related companies with MarketBeat.com's FREE daily email newsletter.